205.417.07051 Boehringer Ingelheim Investigational Site

Saint Petersburg

0 studies enrolling now · 1 studies all time

What they study most

Asthma

Studies at this site

• Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II) — Completed